We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IOM Report May Be Catalyst for Drug Safety Legislation
IOM Report May Be Catalyst for Drug Safety Legislation
January 13, 2006
The National Academies’ Institute of Medicine (IOM) will hold its final drug safety meeting this week in preparation for a long-awaited report that observers say could serve as a catalyst for drug safety legislation.